SMITH & NEPHEW ORD USD0.20

Symbol: SN.

Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.

Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.

Invest in this share within an ISA, JISA, SIPP or Investment Account

Overview

Core Data
Latest Dividend Information

Ex-Dividend Date 1 Oct 2020
Pay Date 28 Oct 2020
Total Dividends - Year to Date29.57
Dividend Yield (%)2.0393

Historical Data & Ratios

Avg Volume Over 10 Days1.6079
Market Cap (M)12797.1500
Price/Earnings (PE)39.879
Earnings Per Share36.36
Revenue Per Share4.5721
Return on Equity %11.9820

1 Month Performance Chart

One Month Chart

Broker View
Data shown is based on the past 75 days of broker views.

ActionBrokers

Strong Buy7

Buy0

Neutral5

Sell0

Strong Sell2

Brokers 7 0 5 0 2
Consensus

ConsensusBuy

Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.

Cost and Charges Information

This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product

Account Type

  • Investment Account
  • Stocks & Shares ISA
  • SIPP

Annual charges

These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate

Cost Category % of Investment lump sum costs
Our annual fee

Our annual fee

Includes our platform fee at 0.35% per annum for Funds (up to £250,000) and Stocks & Shares (min £24 max £240), plus SIPP administration fee (if applicable, only charged if <£30,000 held) - see here
0.35%
Dealing charges

Dealing charges

Any one-off commission charges associated with investing. Note that government taxes and levies are not included
N/A
Product provider costs

Product provider costs

Product provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs
N/A N/A
Total (£)

Total (£)

Costs per annum displayed in monetary value
Total (%)

Total (%)

Costs per annum displayed as a percentage of investment value

Cumulative effect of charges on your investment's return

This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges

lump sum invested with an assumed growth rate of 1 year years
What you might get back at  with no charges applied

What you might get back at  with no charges applied

These are the illustrative values of a  investment after growth and no costs applied at the end of the defined period
Annual charges

Annual charges

These are the annual costs based on an initial investment amount of assuming a net zero growth rate
Effect of charges on return (%)

Effect of charges on return (%)

These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate
Effect of charges on return (£)

Effect of charges on return (£)

These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate
What you might get back at with charges applied

What you might get back at with charges applied

These are the illustrative values of a investment after growth and costs at the end of the defined period

This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use

Charts

  • Chart Options

    Select Timeframe Add a sector as a comparator Add an index as a comparator Add a share as a comparator

      Add a moving average as a comparator Add a lower indicator as a comparator Chart Style Current Comparators

      Company

      Business Summary

      Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

      Financial Summary

      BRIEF: For the six months ended 27 June 2020, Smith & Nephew plc revenues decreased 18% to $2.04B. Net income decreased 68% to $100M. Revenues reflect United States of America segment decrease of 15% to $1.02B, Other Established Markets segment decrease of 20% to $653M, Emerging &internatiuonal market segment decrease of 22% to $361M. Net income also reflects Orthopaedics segment income decrease of 64% to $120M.

      Financials


      Income Statement - All values are in GBP (M).

      Year Ending

      31/12/2019

      31/12/2018

      31/12/2017

      31/12/2016

      31/12/2015

      31/12/2014

      Total Revenue 5,138.00 4,904.00 4,765.00 4,669.00 4,634.00 4,617.00
      Gross profit 3,812.00 3,610.00 3,517.00 3,397.00 3,491.00 3,490.00
      Operating Profit/Loss 815.00 863.00 934.00 1,127.00 628.00 749.00
      Profit Before Tax 743.00 781.00 879.00 1,062.00 559.00 714.00
      Profit After Tax 600.00 663.00 799.00 784.00 410.00 501.00
      Equity Holders of Parent Company 600.00 663.00 767.00 784.00 410.00 501.00
      Minority Interest NIL NIL NIL NIL NIL NIL


      Balance Sheet - All values are in GBP (M).

      Year Ending

      31/12/2019

      31/12/2018

      31/12/2017

      31/12/2016

      31/12/2015

      31/12/2014

      Total Non-Current Assets 6,080.00 4,982.00 5,135.00 4,815.00 4,692.00 4,866.00
      Total Current Assets 3,219.00 3,077.00 2,731.00 2,529.00 2,475.00 2,440.00
      Total Assets 9,299.00 8,059.00 7,866.00 7,344.00 7,167.00 7,306.00
      Total Liabilities 4,158.00 3,185.00 3,222.00 3,386.00 3,201.00 NIL
      Total Net Assets 5,141.00 4,874.00 4,644.00 3,958.00 3,966.00 NIL
      Shareholders Funds 5,141.00 4,874.00 4,644.00 3,958.00 3,966.00 4,040.00
      Minority Interests NIL NIL NIL NIL NIL NIL
      Total Equity 5,141.00 4,874.00 4,644.00 3,958.00 3,966.00 NIL

      Outlook

      Broker View
      Data shown is based on the past 75 days of broker views.

      ActionBrokers

      Strong Buy7

      Buy0

      Neutral5

      Sell0

      Strong Sell2

      Brokers 7 0 5 0 2
      Consensus

      ConsensusBuy

      Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.

      Forecasts

      Year 2020 2021
      Revenue £3,599.54mn £4,138.73mn
      Pre-tax-Profit £311.34mn £693.40mn
      EPS £0.51p £0.80p
      EPS Growth -34.94% 55.32%
      P/E 29.46 19.03
      PEG Ratio -0.84 0.34
      Dividend 21.99p 30.41p
      Yield 1.43% 1.97%

      Upgrades & Downgrades (Latest 10)

      DateBrokerRecommendationPriceOld TargetNew TargetChange
      30th Jul 2020Morgan StanleyReiteration1549p1950p1940pOverweight
      29th Jul 2020Shore CapitalReiteration1619p0p0pSell
      9th Jul 2020Morgan StanleyReiteration1520p2165p2150pBuy

      Time & Sales

      All prices are in GBX and times are in GMT. Last 20 trades shown.

      Date Time Price Volume Type
      22 Sep 2020 16:35 1,451.5 3,000 Sell
      22 Sep 2020 16:35 1,451.5 702 Sell
      22 Sep 2020 16:35 1,451.5 543,550 Sell
      22 Sep 2020 16:29 1,458 147 Buy
      22 Sep 2020 16:29 1,458 228 Sell
      22 Sep 2020 16:29 1,458.5 1 Buy
      22 Sep 2020 16:29 1,457.5 201 Sell
      22 Sep 2020 16:29 1,457.5 49 Sell
      22 Sep 2020 16:29 1,457.5 224 Buy
      22 Sep 2020 16:29 1,458.5 250 Buy
      22 Sep 2020 16:29 1,458.5 147 Buy
      22 Sep 2020 16:29 1,458 156 Buy
      22 Sep 2020 16:29 1,458 71 Buy
      22 Sep 2020 16:29 1,457.5 391 Buy
      22 Sep 2020 16:29 1,457.5 405 Buy
      22 Sep 2020 16:29 1,457.5 622 Buy
      22 Sep 2020 16:29 1,458 9 Buy
      22 Sep 2020 16:29 1,457.5 560 Buy
      22 Sep 2020 16:29 1,457.5 104 Buy
      22 Sep 2020 16:29 1,457.5 278 Buy

      Selected data supplied by Thomson Reuters ©  View restrictions.

      Investment involves risk. You may get back less than invested.